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Novos líquidos iônicos aquirais e quirais foram preparados utilizando-se rotas sintéticas 
inéditas e/ou otimizadas. Estas séries de líquidos iônicos do tipo imidazolínico, imidazólico e 
piridínico foram totalmente caracterizadas, incluindo-se análises por calorimetria diferencial de 
varredura (DSC). O desempenho desses líquidos iônicos (LIs) foi demonstrado empregando-se a 
arilação de Heck de aza-acrilato endocíclicos com sais de arenodiazônio ou iodetos de arila. As 
arilações de Heck realizadas na presença destas entidades iônicas quirais, seja como um solvente 
ou um aditivo, foram eficazes levando à completa conversão do substrato, em bons a excelentes 
rendimentos do aduto de Heck na maioria dos casos, apesar de não ser observada indução 
assimétrica em nenhum dos casos estudados. Dois novos complexos quirais de paládio do tipo 
carbeno N-heterocíclico foram preparados em bons rendimentos a partir de um sal imidazólico 
quiral e suas estruturas caracterizadas por difração de raios-X. De modo geral, a arilação de Heck 
empregando tetrafluoroboratos de arenodiazônio em líquidos iônicos demonstrou ser mais eficiente 
do que os protocolos tradicionais em termos de reatividade e rendimentos de reação.
New achiral and chiral RTILs were prepared using novel and/or optimized synthetic routes. 
These new series of imidazolinium, imidazolium, pyridinium and nicotine-derived ionic liquids were 
fully characterized including differential scanning calorimetry (DSC) analysis. The performance 
of these achiral and chiral room temperature ionic liquids (RTILs) was demonstrated by means 
of the Heck arylation of endocyclic acrylates employing arenediazonium salts and aryl iodides. 
The Heck arylations performed in the presence of these ionic entities, either as a solvent or as an 
additive, were effective leading to complete conversion of the substrate and good to excellent yield 
of the Heck adduct. In spite of the good performances, no asymmetric induction was observed in 
any of the cases studied. Two new diastereoisomeric NHC-palladium complexes were prepared in 
good yields from a chiral imidazolium salt and their structure characterized by X-ray diffraction. 
Overall, the Heck arylations employing arenediazonium tetrafluoroborates in RTILs were more 
effective than the traditional protocols employing aryl iodides in terms of reactivity and yields. 
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Introduction
Room temperature ionic liquids (RTILs) have been 
proposed as a safer and more eco-friendly alternative 
to classical organic solvents.1 In addition, they can 
offer unique opportunities to modulate the course of a 
reaction, which combined with their highly adaptable 
structure opens up almost unlimited prospects in 
synthesis.2 In the context of homogenous catalysis, in 
particular with Pd(0), RTILs have also proven to be 
highly beneficial, contributing to catalyst stabilization, 
immobilization and recovery.3 
Among the Pd(0)-catalyzed C-C coupling reactions 
employed in multi-step synthesis, the Heck reaction 
plays a preponderant role. However, Heck arylations 
employing arenediazonium salts as electrophiles have 
received relatively less attention in comparison to the more 
traditional aryl halide- or triflate-based arylation protocols.4 
Yet, arenediazonium salts offer several economical, 
environmental and practical advantages over aryl halides. 
Arenediazonium salts are easily prepared, are often less 
expensive than the aryl halides, provide faster palladium-
catalyzed arylation reactions, are used under phosphine-
free conditions and allow more user-friendly open-air 
experimental conditions. Surprisingly, the Heck arylation 
employing arenediazonium salts have been scarcely studied 
in RTILs.5
In view of the increasing importance of RTILs as 
reaction media in organic synthesis, several groups have 
recently focused on the synthesis of chiral ionic liquids 
(CILs), particularly for their potential applications to chiral 
discrimination and to optical resolution of racemates.6 
Main advantages of using water-immiscible CILs 
as solvents include the following: (i) the CILs are 
inexpensively, easily made, and can be recycled; 
(ii) enantiomers of the ionic liquids can be synthesized; 
(iii) they are easily removed from the reaction mixture, 
and as a result the analyses are usually simpler and more 
accurate. Additionally, because of their high degree of 
organization and ionic properties there is also a potential for 
a more effective solvent-solute interaction and ion-paring 
formation. The impact of the latter effect on chirality transfer 
has been illustrated by Wasserscheid and co-workers7 who 
reported the asymmetric hydrogenation of a prochiral 
imidazolium salt embedding a chiral camphorsulfonate 
anion with the enantioselectivity reaching 94%.
However, despite the large variety of CILs reported 
so far, their use as reaction media in asymmetric 
transformations has met with limited success in term of 
chiral induction.8 For example, Armstrong et al.9 reported 
on an enantioselective photoisomerisation induced 
by a chiral ionic liquid (12% ee), and Vo-Thanh and 
co-workers10 demonstrated that asymmetric inductions of 
up to 44% ee could be achieved using CILs as reaction 
media for the Baylis-Hillman reaction. More recently, 
Afonso et al.11 disclosed the application of CILs as 
an asymmetric inducing agent in the catalytic Rh(II) 
carbenoid C-H insertion (27% ee) and in the Sharpless 
dihydroxylation (85% ee). Finally, the highest level of 
induced enantioselectivity reported to date by a solvent 
as the only source of chirality in an asymmetric reaction 
was described by Leitner and co-workers.12 Using a 
specifically designed ionic liquid with a chiral anion, 
enantioselectivities of up to 84% ee were obtained in the 
aza-Baylis-Hillman reaction. These results are comparable 
with the values obtained with the best catalysts for 
the enantioselective aza-Baylis-Hillman reaction in 
conventional solvents (94% ee,13 83% ee14). 
These results indicate that the key to effective chirality 
transfer lies in strong intermolecular interactions such as 
electrostatic attraction and hydrogen bonding between the 
solvent molecules and the intermediates or the transition 
states of the enantioselective reaction step.
In view of their intrinsic structural flexibility, RTILs 
also offer wide prospects for potential chirality transfer in 
organometallic catalysis. This includes in situ generation of 
the active catalyst through carbene palladium complexes. 
Indeed, the participation of 1,3-dialkylimidazolium-type 
ionic liquids in the stabilization of catalytic Pd species, 
related to the so-called “non-innocent” nature of these 
cations, has been proposed in several cases.15 In particular, 
in the course of Heck arylation16 and Suzuki cross-
coupling,17 1,2-diaminocarbenes formed in situ from an 
imidazolium-based ionic liquid have been suggested to be 
involved as Pd ligands. 
However, examples of asymmetric versions of 
this approach based on the use of chiral ionic reaction 
medium remain scarce. Kiss et al.18 have notably studied 
the influence of a 1-((S)-2-methylbutyl)imidazolium 
hexafluorophosphate on the stereochemical course of a Heck 
oxyarylation reaction. Although the enantioselectivities 
observed were very modest (4-5% ee), this interesting 
precedent validated the concept. 
The eventuality of creating a stereogenic center in a 
stereocontrolled manner in the course of the Heck reaction 
would certainly contribute to strengthen its synthetic 
potential. In line with our continuous efforts to widen the 
scope and demonstrate the potential of the Heck arylation 
with arenediazonium in multi-step synthesis of bioactive 
compounds,19 we recently reported a new synthesis of the 
antidepressant drug (±)-paroxetine (4) (Scheme 1).20
Our synthetic route was based on a fast, clean and simple 
palladium-catalyzed arylation of a substituted acrylate in 
CH3CN/H2O (2:1) with Pd(OAc)2 as catalyst. Application 
of this protocol to the aza-endocyclic acrylate 1 afforded 
an efficient access to an arylated tetrahydropyridine 2. 
We wish to report herein the synthesis of several chiral 
ionic liquids, as well as our initial results concerning the 
performance of these new ionic species as reaction media 
and additive for the Heck arylation of aza-endocyclic 
acrylates employing either arenediazonium salts or aryl 
iodides as electrophiles.
 
Results and Discussion
The aza-endocyclic acrylate 1 was employed in our 
previous total synthesis of (±)-paroxetine (4). However, 
in the context of the present study, it was found more 
advantageous to employ the N-phenoxycarbonyl starting 
tetrahydropyridine 6, since it can be prepared in one step 
from arecoline hydrobromide (5), in 76% yield (Scheme 2).
Use of achiral ionic media for the key Heck arylation
We first  screened a series  of  1-n-butyl-3-
methylimidazolium (BMIM) salts as a reaction media for 
the Heck arylation reaction (Table 1). A standard protocol 
was established as follows: the arenediazonium salt and 
the Pd(OAc)2 were simultaneously added to a solution of 
the olefin in the RTIL and the reaction mixture was rapidly 
heated to 65-70 °C. Alternatively, complete solubilization 
of the palladium acetate could be first ensured by a brief 
sonication before addition of the arenediazonium salt, giving 
essentially the same results. The expected Heck product was 
accompanied by a side product which revealed to be the 
carboxylic acid derivative generated by acidic hydrolysis 
of the a,β-unsaturated methyl ester. The feasibility of 
the palladium catalyzed process was found to be highly 
dependent on the nature of the imidazolium counter-ion.21 
These observations paralleled Kabalka’s study.5 Heck 
arylations were sluggish in [BMIM][Br] and [BMIM]
[BF4], providing low conversion and decomposition under 
forced conditions (Table 1, entries 1 and 2). On the other 
hand, the reaction proceeded smoothly in the hydrophobic 
RTILs embedding an hexafluorophosphate (PF6–) as well 
as a bis(trifluoromethanesulfonyl)imide (NTf2–) anion.22 
Complete and clean conversions were observed after only one 
hour at 65 °C, thus allowing isolation of the expected adduct 
in good yields (Table 1, entries 3 to 5). Interestingly, the 
reaction worked equally well in [BDIM][NTf2] (1-n-butyl-
2,3-dimethylimidazolium bis(trifluoromethanesulfonyl)
imide) where the critical C-2 position of the imidazolium 
cation is substituted with a methyl group (Table 1, entries 
5 and 6). The use of Pd(OAc)2 or Pd2(dba)3 as pre-catalyst 
gave comparable results (compare entries 3 and 4 or entries 
6 and 7). Several bases were also tested in [BMIM][NTf2] 
in order to neutralize the HBF4 produced in the course of the 
reaction. Remarkably, the presence of 2 equivalents of either 
DIPEA, K2CO3 or NaOAc totally precluded the reaction. 
The same trend has previously been observed in protic 
solvents and might be imputed to the relative instability of 
the arenediazonium salt in basic media. 
In order to better evaluate the performance of 
arenediazonium salts in RTILs, the reactivity of other 
electrophiles was also assessed. A first set of experiments 
was run at 100 °C. Phenyl triflate revealed ineffective in the 
presence of NaOAc in [BMIM][NTf2] (Table 1, entry 8) and 
the same outcome was observed using iodobenzene with 
NaOAc in [BMIM][Br] (Table 1, entry 9). An encouraging 
result was obtained with the iodobenzene thanks to the 
use of Ag2CO3 in [BMIM][NTf2] (Table 1, entry 10). 
Since a comparable result was obtained with 1-fluoro-4-
iodobenzene (Table 1, entry 11) we briefly optimized these 
conditions (Table 1, entries 12 to 15). Running the reaction 
at 120 °C for 5 h with Pd(OAc)2 in [BDIM][NTf2] gave rise 
to a reasonably efficient process (Table 1, entries 14) while 
the use of Pd2(dba)3 proved much less efficient. Altogether, 
these observations confirmed the higher reactivity of 
arenediazonium salts as compared to other electrophilic 
reagents, even in ionic media.
With the feasibility of the key Heck arylation step of 
our synthesis of paroxetine in RTILs ensured, we then 
turned our attention toward the use of chiral media. A chiral 
environment surrounding the metal might indeed lead to 
some asymmetric induction in the course of the migratory 
insertion step during which the stereogenic center is created. 
Ordinary asymmetric induction in the course of the Heck 
coupling with arenediazonium salts is a challenging task 
Scheme 1. The Heck arylation with an arenediazonium salt as a key step 
of the synthesis of (±)-paroxetine (4).7
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though, partly because of the arenediazonium instability 
in the presence of the phosphine ligands. Moreover, the 
use of chiral RTILs as medium for the more traditional 
Heck reactions employing aryl halides and aryl triflates as 
arylating agents were also evaluated.
Use of C-2 unsubstituted imidazolinium and imidazolium 
chiral ionic liquid
In the first part of this study we focused on the possible 
interaction between the palladium-based catalytic species 
and the chiral imidazolium cation of the ionic liquid through 
the C-2 position, bearing in mind the opportunities for the 
in situ formation of imidazol-2-ylidene metal complexes.
Preparation of the chiral ionic liquids
Access to C-2 unsubstituted chiral imidazolinium/
imidazolium salts was envisioned from the corresponding 
imidazoline/imidazole through a straightforward 
quaternarisation/anion metathesis sequence (Scheme 3). 
The imidazolinic precursors were prepared according to 
our previously described route based on the condensation 
between an orthoester and the chiral diamine 9.23 Preparation 
of the latter was carefully optimized: slow addition 
(2 mL h-1) of a concentrated (5.4 mol L-1) aqueous solution 
of 2-chloroethylamine to neat chiral amine (2 equiv.) at 
80 °C provided, after workup, a crude mixture from 
which the excess of chiral amine was distilled off 
(40-50 °C/3 × 10-2 mbar). A bulb to bulb distillation 
(90-100 °C/3 × 10-2 mbar) allowed isolation of the pure chiral 
diamine 9 in 60% yield. The use of triethylorthoformate as the 
orthoester gave access to C-2 unsubstituted imidazoline 10. 
Aromatising dehydrogenation then produced the corresponding 
imidazole 14.23 We found that this transformation can be 
accomplished in a few minutes by the use of the commercially 
available NiO2 (8 equiv.) in acetonitrile under microwave 
activation (200W irradiation while cooling with compressed 
air so as to maintain the temperature at 90 °C). The imidazole 
14 was thus obtained in 50% yield after a simple filtration 
over grade III alumina. Alternatively, this compound can 
be prepared by means of a cyclocondensation reaction24 
Table 1. The key Heck arylation reaction in various RTILs
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Entry Ra X RTIL Pre-catalystb Base T (°C) t (h) Conv. (%)c Yield (%)
d
 
ester/acid
1 F N2BF4 [BMIM][Br] Pd(OAc)2 / 70 48 11 59/11
2 F N2BF4 [BMIM][BF4] Pd(OAc)2 / 65 72 66 35/12
3 F N2BF4 [BMIM][PF6] Pd(OAc)2 / 65 1 100 75/16
4 F N2BF4 [BMIM][PF6] Pd2(dba)3 / 65 1 100 77/5
5 F N2BF4 [BMIM][NTf2] Pd(OAc)2 / 65 1 100 71/18
6 F N2BF4 [BDIM][NTf2] e Pd(OAc)2 / 65 1 100 72/17
7 F N2BF4 [BDIM][NTf2] e Pd2(dba)3 / 65 1 100 70/18
8 H OTf f [BMIM][NTf2] Pd(OAc)2 NaOAc g 100 24 0 /
9 H I f [BMIM][Br] Pd(OAc)2 NaOAc g 100 24 0 /
10 H I f [BMIM][NTf2] Pd(OAc)2 Ag2CO3 h 100 24 46 56/0
11 F I i [BMIM][NTf2] Pd(OAc)2 Ag2CO3 h 100 22 45 30/0
12 F I i [BMIM][NTf2] Pd(OAc)2 Ag2CO3 h 120 5 55 82/0
13 F I i [BMIM][NTf2] Pd2(dba)3 Ag2CO3 h 120 24 45 9/0
14 F I i [BDIM][NTf2] e Pd(OAc)2 Ag2CO3 h 120 5 100 68/0
15 F I i [BDIM][NTf2] e Pd2(dba)3 Ag2CO3 h 120 24 63 35/0
a Unless otherwise stated, 1.5 equiv. of electrophile were used; b Pd(OAc)2 10 mol%; Pd2(dba)3 5 mol%; c Conversion calculated on the basis of the recovered 
starting material; d Isolated yields, based on starting material recovering, when appropriate; e [BDIM] = 1-n-butyl-2,3-dimethylimidazolium; f 2.0 equiv. of 
halide were used; g 1.5 equiv. of base were used; h 1.1 equiv. of base were used; i 3.0 equiv. of halide were used.
from glyceraldehyde, a-methylbenzylamine, formaldehyde 
and ammonium acetate using the Saigo’s procedure (70% 
yield).25 Prolonged reflux of the imidazoline 10 or imidazole 
14 in 1,1,1-trichloroethane in the presence of an excess of 
1-bromopentane furnished the expected 3-pentyl derivatives 
11 and 15, respectively. Treatment of the imidazole 14 with 
methyl iodide at room temperature in acetonitrile smoothly 
delivered the 3-methylimidazolium 16. In order to enhance 
chances of interactions between the catalytic palladium 
species and the imidazolium nucleus of the ionic solvent 
we also prepared the imidazolium salt 17 in which the alkyl 
chain bears a coordinating nitrile functionality.26 Indeed, 
mechanistic studies from our laboratories have shown the 
role of the solvent acetonitrile in stabilizing catalytic species 
generated from Pd2(dba)3 in the course of the Heck arylation 
with arenediazonium salts.27 
At this stage, it appeared critical to control the enantiomeric 
purity of our derivatives. This was realized by 1H NMR 
analysis of the representative imidazolium bromide 15. The 
chiral shift reagent tris[3-trifluoromethylhydroxymethylene)-
D-camphorato] europium III allowed splitting (Δδ = 0.1 ppm) 
of the H-2 signal of the racemate at 12.78 ppm in CDCl3. 
Analysis of the enantiopure material under the same 
conditions clearly demonstrated the absence of any detectable 
racemization. This high degree of enantiomeric purity was 
independent of the procedure used to prepare the chiral 
imidazole precursor.
The preparation of the targeted ionic liquids required 
a final anion metathesis step, which was performed 
using known procedures (Scheme 3). The imidazolinium 
hexafluorophosphate salt 12 was prepared from the 
corresponding acid (64% yield) as a solid melting at 
86-87 °C. The bis(trifluoromethanesulfonyl)imide was 
introduced by mean of the corresponding lithium salt 
yielding imidazolinium 13 (80% yield), and imidazolium 
18-20 (79-88% yield). Interestingly, 1H NMR analysis 
of the imidazolium 20 revealed that the H-2 proton 
had become highly exchangeable with deuterium, thus 
indicating an increased acidity.
All these salts are liquid at room temperature and 
differential scanning calorimetry (DSC) analyses were 
recorded in order to characterize the thermal behaviour 
of these new chiral ionic liquids. In sharp contrast with 
its hexafluorophosphate counterpart (mp 86-87 °C), the 
imidazolinium bis(trifluoromethanesulfonyl)imide 13 
displayed glass transition (Tg) at –59 °C. A comparable 
Tg of –57 °C was found for the corresponding n-pentyl 
imidazolium salt 18. This behaviour parallels, yet to a lesser 
extent, what we previously observed in the C-2-substituted 
series in which the aromatic imidazolium salts displayed 
Tg values 7 to 11 °C higher than the corresponding 
imidazolinium derivatives. Overall, the lack of substituent 
at C-2 lowered the Tg values which were of –55 °C and 
–48 °C for the corresponding 2-ethyl derivatives. Finally 
the side chain was also found to exert a certain influence on 
the thermal behaviour of these salts since a slightly higher 
Tg of –50 °C was observed for the methyl imidazolium 
bis(trifluoromethanesulfonyl)imide 19, whereas the nitrile 
substituted derivative 20 displayed a glass transition at 
–46 °C.
Evaluation of the chiral ionic liquids
In order to evaluate the asymmetric induction 
effectively, analytical conditions were sought for the key 
arylated product. The enantiomers of 7a were readily 
resolved by HPLC using a Chiralcel OD column (Hexane/ 
i-PrOH 70:30 (v:v), Rt = 6.6 min and 11.5 min). Separation 
was sufficient to allow isolation of an enantiomerically 
pure sample of each enantiomers on a semi-preparative 
column. Characterization of the arylated compound 7a in an 
enantiopure form allowed assessment of its configurational 
stability. Importantly, no racemisation was observed, as 
judged by chiral HPLC analysis, after prolonged heating of 
7a in basic media (Ag2CO3, [BMIM][NTf2], 120 °C, 24 h).
On a strictly chemical standpoint, the nature of 
the RTIL was found to have a certain influence on the 
course of the reaction. In the imidazolinium series the 
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Scheme 3. Preparation of the imidazolinium and imidazolium chiral 
RTILs.
bis(trifluoromethanesulfonyl)imide salt 13 revealed less 
favourable, even under more vigourous conditions, than 
the hexafluorophosphate salt 12 which allowed smooth 
and clean conversion of the starting acrylate (Table 2, 
entries 1, 2 and 3). As far as the imidazolium salts were 
concerned, the 3-pentyl derivative 18 gave the best result. 
Unexpectedly, the reaction proved rather sluggish when 
the less hindered 3-methyl imidazolium salt 19 was used, 
which might be correlated to an increase in viscosity 
(Table 2, entry 6). A complete conversion was achieved with 
the nitrile-functionalized salt 20 after prolonged heating 
with Pd2(dba)3 as a pre-catalyst which presented a marked 
contrast with Pd(OAc)2 (Table 2, entries 7 and 8). 
Several of these chiral RTILs gave rise to an efficient 
transformation, although the enantiomeric excess of the 
isolated product was found negligible, independently of the 
chiral ionic liquid used. In order to ensure that this behavior 
was not due to a mechanistic particularity of the Heck 
arylation employing arenediazonium salts, we performed 
the Heck arylation with the corresponding aryl iodide. 
When the olefin 6 was treated with 1-fluoro-4-iodobenzene 
in the chiral imidazolium 18 a satisfactory transformation 
was obtained (Table 2, entry 5), but unfortunately no 
asymmetric induction was evidenced in the Heck adduct.
Preparation and use of imidazolium-derived diaminocarbene 
Pd complexes
Aiming at increasing the interaction between the 
imidazolium nucleus of the RTIL and the palladium 
catalyst, we also studied the use of imidazolium-derived 
pre-formed diaminocarbene palladium complexes.28
Thus ,  we  f i r s t  p repared  the  1 -n -bu ty l -3 -
methylimidazolium bromide-derived N-heterocyclic 
carbene palladium complex 22 described by Xiao 
(Scheme 4).16 The latter was generated from Pd(OAc)2 in 
refluxing THF in 77% isolated yield as the sole trans isomer 
(anti/syn, 1:1). When evaluated in our model reaction of 
6 with 4-fluorobenzenediazonium tetrafluoroborate, this 
entity proved poorly active in [BMIM][Br] (20 mol%, 
80 °C, 48 h, 9% yield bsmr at 60% of conversion) and 
totally inefficient in [BMIM][PF6] (20 mol%, 65 °C, 24 h).
Table 2. The Heck arylation in various imidazolinium and imidazolium chiral RTILs
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Entry a X RTIL Pre-catalyst b T (°C) t (h) Conv. (%) c Yield (%) 
d
 
ester/acid
1 N2BF4 12 Pd(OAc)2 90 6 100 72/0
2 N2BF4 13 Pd(OAc)2 65 27 26 50/0
3 N2BF4 13 Pd(OAc)2 90 7 39 53/0
4 N2BF4 18 Pd(OAc)2 65 6 100 66/24
5e If 18 Pd(OAc)2 90 4 50 74/0
6 N2BF4 19 Pd(OAc)2 65 11 23 47/0
7 N2BF4 20 Pd(OAc)2 65 5 27 79/0
8 N2BF4 20 Pd2(dba)3 65 24 100 53/10
a 1.5 equiv. of the arenediazonium salt was used; b Pd(OAc)2 10 mol%; Pd2(dba)3 5 mol%; c Conversion calculated on the basis of the recovered starting 
material; d Isolated yields, based on starting material recovering; e 1.1 equiv. of the base Ag2CO3 were used; f 2.0 equiv. of iodide were used.
In parallel, the behaviour of our chiral imidazolium 
cation in the presence of Pd(OAc)2 was also explored by 
means of the reaction of the bromide 15 with 0.5 equiv. 
of the palladium salt in refluxing THF (Scheme 3). A 
smooth transformation occurred after heating 15 with 
Pd(OAc)2 for 6 h, allowing isolation of the expected 
palladium complex 23 in 54% yield as a 1:1 mixture of 
isomers according to 1H and 13C NMR. Assignment of 
the stereochemical identity of these diaminocarbenes 
complexes was not trivial. Gratifyingly, a single crystal 
suitable for X-ray diffraction analysis could be obtained 
for each isomer thus allowing to identify the two 
products as the trans-anti isomer 23a along with the 
quite unexpected cis-syn derivative 23b (Figure 1).29 A 
π-stacking interaction between the phenyl groups of each 
diaminocarbene moieties might account for the formation 
of this strained isomer.
The mixture of isomers 23a, b was evaluated in our 
key Heck arylation with 4-fluorobenzenediazonium 
tetrafluoroborate. However, the use of 10-20 mol% of 
these complexes in either THF (reflux, 24 h), CH3CN 
(reflux, 24 h), or [BMIM][PF6] (100 °C, 24 h) failed 
to induce any transformation. The same behavior 
was observed when 1-fluoro-4-iodobenzene was used 
(3.0 equiv. Ag2CO3, DMF, 130 °C, 24 h). The intrinsic 
stability of these bis-diaminocarbene palladium complexes 
might be responsible for their lack of catalytic activity.
Use of an hydroxylated chiral ionic liquid 
In the course of the development of our synthetic 
methodology we found out that the key Heck reaction 
could be run efficiently in MeOH. The beneficial effect 
of protic solvents prompted us to explore the influence 
of hydroxyl-containing chiral ionic liquids for this 
transformation. 
We took advantage here of the preparation of the 
phenylglycinol derivative 26 we reported recently.30 
This ionic liquid was synthesized from pyridinium 25 
employing a route previously described by us based 
on the use of the Zincke reaction (Scheme 5).31 The 
bis(trifluoromethanesulfonyl)imide anion was selected 
on the basis of previous studies.32 To our satisfaction, it 
was found that this hydroxylated derivative displayed a 
Tg of –45 °C measured by DSC analysis as compared to 
–30 °C for the its non-hydroxylated counterpart 24.32 The 
latter was also considered for the matter of comparison.
The unsubstituted a-methylbenzylamine-derived 
salt 24 gave rise to a smooth transformation with 
4-fluorobenzenediazonium tetrafluoroborate (Table 3, 
entry 1). Despite the high tolerance of the key Heck 
coupling for alcoholic media, the reaction in the 
hydroxylated derivative 26 proved much less efficient, 
irrespectively to the pre-catalyst (Table 3, entries 2 and 3). 
The conversions were not altered, but the yields were 
strongly affected. For the sake of comparison, the iodide 
was also evaluated as under the reaction conditions 
determined previously (Table 3, entries 4 and 5). As 
observed before, Pd(OAc)2 was more efficient than 
Pd2(dba)3. Notably, in this case the halide gave rise 
to a better transformation than the corresponding 
arenediazonium salt. Unfortunately, no enantiomeric 
excess was detected from the analysis of the isolated 
products.
N NR Me
n
+
_
Br
21, R = Me, n = 3
15, R = (S)-Ph(Me)CH, n = 4
Pd(OAc)2 (0.5 equiv.)
THF, reflux
22, R = Me, n = 3 (trans-syn/trans-anti 1:1) (77%)
23, R = (S)-Ph(Me)CH, n = 4 (cis-syn/trans-anti 1:1) (54%)
PdBr2
N
N
Me
R
n
2
Scheme 4. Preparation of palladium complexes from imidazolium salts.
Figure 1. X-ray structure of the trans-anti 23a (left) and cis-syn 23b (right) 
diaminocarbene Pd complexes obtained from the chiral imidazolium 15 
and Pd(OAc)2.19
+
_N
MePh
NTf2
N
NO2
NO2
+ Cl
_
+
_
N
Ph
NTf2
OH
ref. 30ref. 32
24 (74%) 26 (61%)25
Scheme 5. Preparation of the pyridinium chiral RTILs.
The use of chiral ionic liquid bearing a basic functionality 
as a potential coordination site
In the last part of this study we adopted an alternative 
strategy. In order to drive the interaction between the ionic 
liquid and the catalytic species we opted for the use of 
chiral ionic entities bearing a N-heterocycle susceptible to 
coordination to the metal centre. Indeed, several studies 
by Shreeve and co-workers33 have recently described 
catalytically active entities based on the complex between 
a palladium salt and an ionic liquid bearing a basic 
functionality. To the best of our knowledge, no examples 
of chiral derivative of that kind were reported so far. We 
reasoned that such electron-rich entities might interact 
significantly with the cationic palladium species involved in 
the catalytic cycle operating in the case of arenediazonium 
salts. 
We first focused on the readily accessible nicotine 
derivative. Albrecht has recently used such a pyridinium 
halide as a carbene precursor to prepare a catalytically active 
palladium complex.34 The quaternarization of nicotine had 
already been described earlier by Shibagaki et al.35 who 
showed that it was possible to chemoselectively N-alkylate 
the pyridine nucleus versus the pyrrolidine ring on the 
basis of steric considerations. However, as the yields and 
conversion reported were not satisfactory we first optimized 
the access to the required pyridinium salt. In this regard, 
the use of microwave activation proved highly efficient. 
Indeed, treatment of the nicotine (27) with i-propyl iodide 
in CH3CN at 100 °C under microwave irradiation led to the 
clean and efficient formation of the expected pyridinium 
iodide 28 in only 2 h (Scheme 6). Anion metathesis 
proceeded uneventfully for this iodide salt to afford the 
desired chiral pyridinium bis(trifluoromethanesulfonyl)
imide 29. The latter displayed a glass transition at –56 °C 
measured by DSC.
We then evaluated the influence of this chiral pyridinium 
as an additive in the course of our model arylation (Table 4). 
Since HBF4 is formed during the transformation, 1.2 equiv. of 
the basic ionic liquid were used. On the other hand, the C-2 
methyl derivative [BDIM][NTf2] was selected as a potentially 
“innocent” ionic media, although carbene formation at C-4 
and C-5 of the imdazolium ring has also been reported.36 The 
presence of the additive strongly changed the conversion in 
Table 3. The Heck arylation in hydroxylated and non-hydroxylated chiral pyridinium RTILs
+
_
N
Ph
NTf2
OH
26
+ _
N
MePh
NTf2
24
RTILs:
N
CO2Ph
N
OCH3
CO2Ph
O
Pd pre-catalyst OCH3
O
F
F X
RTIL, ∆ N
CO2Ph
OH
O
F
+
6 7a 8a
Entry X a RTIL Catalyst b T (°C) t (h) Conv. (%) c Yield (%) 
d
 
ester/acid
1 N2BF4 24 Pd(OAc)2 65 1 100 53/18
2 N2BF4 26 Pd(OAc)2 65 1.5 100 34/4
3 N2BF4 26 Pd2(dba)3 65 1.5 100 21/3
4 e I 26 Pd(OAc)2 120 1 100 80/0
5 e I 26 Pd2(dba)3 120 2 100 51/0
a 1.5 equiv. of arenediazonium salt and 3.0 equiv. of iodide were used; b Pd(OAc)2 10 mol%; Pd2(dba)3 5 mol%; c Conversion calculated on the basis of the 
recovered starting material; d Isolated yields, based on starting material recovering; e 1.1 equiv. of the base Ag2CO3 was used.
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Me
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N
Me
Me Me
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Scheme 6. Preparation of the nicotine-derived chiral RTIL 29.
the case of 4-fluorobenzenediazonium tetrafluoroborate and 
of the aryl iodide counterpart. In spite of lower conversions, 
yields were higher using the aryl halide (Table 4, entries 
3 and 4). This observation might be related with some 
decomposition of the arenediazonium salt in the reaction 
media.
Another pyridinium ionic liquid bearing a chiral 
pyrrolidine moiety was prepared by the Zincke reaction 
(Scheme 7). Thus, treatment of the so-called Zincke salt 
by the commercially available chiral primary amine 30 
afforded the desired pyridinium chloride 31, which upon 
anion metathesis provided the bis(trifluoromethanesulfonyl)
imide salt 32 in 35% overall yield. A Tg of –52 °C was 
measured by DSC for this chiral ionic liquid.
The impact of the chiral pyridinium ionic liquid 32 on 
the outcome of the Heck reaction is similar that observed 
previously for the ionic liquid 29 (Table 4). The basic nature 
of the additive seems to hamper the transformation, although 
to a lesser extent than that observed with the nicotine-
Table 4. The Heck arylation in an achiral ionic media in the presence of different chiral ionic additives
N
N
Me
Me Me
+
NTf2
_
29
N N
Me
Ph
N
n-Bu
NTf2
35
N
CO2Ph
N
OCH3
CO2Ph
O
Pd pre-catalyst OCH3
O
F
F X
solvent,  ∆
6 7a
29 or 32 or 35
(1.2 equiv.)
32
N
N
Et
NTf2
Chiral ionic additives:
N
CO2Ph
OH
O
F
+
8a
Entry Additive X a Solvent Pre-catalyst b T (°C) t (h) Conv. (%) c Yield (%) 
d
 
ester/acid
1 29 N2BF4 [BDMIM][NTf2] Pd(OAc)2 65 24 31 47/0
2 29 N2BF4 [BDMIM][NTf2] Pd2(dba)3 65 24 23 52/0
3e 29 I [BDMIM][NTf2] Pd(OAc)2 120 24 9 80/0
4e 29 I [BDMIM][NTf2] Pd2(dba)3 120 24 12 92/0
5 32 N2BF4 [BDIM][NTf2] Pd(OAc)2 65 24 47 57/0
6 32 N2BF4 [BDIM][NTf2] Pd2(dba)3 65 24 32 47/0
7 32 N2BF4 THF Pd(OAc)2 65 24 19 100/0
8 32 N2BF4 THF Pd2(dba)3 65 24 11 31/0
9 e 32 I [BDIM][NTf2] Pd(OAc)2 120 24 29 91/0
10 e 32 I [BDIM][NTf2] Pd2(dba)3 120 24 14 70/0
11 35 N2BF4 [BDIM][NTf2] Pd(OAc)2 65 24 100 90/0
12 35 N2BF4 [BDIM][NTf2] Pd2(dba)3 65 24 100 96/0
13 35 N2BF4 THF Pd(OAc)2 65 3 54 84/0
14 35 N2BF4 THF Pd2(dba)3 65 3 31 86/0
15 e 35 I [BDIM][NTf2] Pd(OAc)2 120 7 100 58/0
16 e 35 I [BDIM][NTf2] Pd2(dba)3 120 24 45 55/0
a 1.5 equiv. of arenediazonium salt and 3.0 equiv. of iodide were used; b Pd(OAc)2 10 mol%; Pd2(dba)3 5 mol%; c Conversion calculated on the basis of the 
recovered starting material; d Isolated yields, based on starting material recovering; e 1.1 equiv. of the base Ag2CO3 was used.
N
NO2
NO2
+ Cl
n-BuOH 
reflux
N
+
N
Et
Cl
31 (51%)
N
NH2
Et
25
30 N
+
N
Et
NTf2
32 (67%)
 LiNTf2
H2O
Scheme 7. Synthesis of the chiral pyridinium RTIL 33 by means of the 
Zincke reaction.
derived pyridinium salt. For comparison, the reaction 
with the 4-fluorobenzenediazonium tetrafluoroborate was 
also carried out in THF instead of [BDIM][NTf2] and the 
conversions were even lower in this molecular solvent 
(Table 4, entries 7 and 8).
Finally, in an attempt to reduce the basicity of the 
chiral additive, we turned our attention to the possibility 
of introducing a heteroaromatic appendage into the 
structure of the ionic liquid. Shreeve has described a 
series of achiral 2-imidazolyl or 2-pyridylimidazolium 
salt useful for the preparation of palladium complexes.33 
In line with this work we envisioned the synthesis of such 
compounds from a chiral primary amine by means of a 
one-pot multi-component reaction. Although application 
of this route to the preparation of chiral 2,2’-bisimidazole 
did not appear viable,37 we succeeded in preparing a 
2-pyrydylimidazole. Indeed, after careful optimization 
it was found that treatment of a-methylbenzylamine 
with glyoxal, ammonium hydroxide and pyridine-2-
carboxaldehyde furnished imidazole 33 in 18% yield 
(Scheme 8).
Quaternarization of the more basic imidazole nucleus 
was then carried out in a highly convenient and efficient 
manner. Microwave activation and anion metathesis step 
provided the expected chiral ionic liquid 35 in 76% overall 
yield (Scheme 8). Despite the presence of the aromatic 
substituent at C-2, this bis(trifluoromethanesulfonyl)imide 
salt displayed a Tg of –40 °C as measured by DSC.
The less basic additive 35 was found to be fully 
compatible with the use of 4-fluorobenzenediazonium 
tetrafluoroborate in our key palladium-catalyzed arylation 
(Table 4). The expected product was isolated in high yield, 
although the transformation appeared to be slower in 
[BDIM][NTf2] (Table 4, entries 11 and 12). Remarkably, in 
this particular case the pre-catalyst Pd2(dba)3 gave a better 
result than Pd(OAc)2. A sluggish, yet clean, reaction was 
also observed in THF (Table 4, entries 13 and 14). The aryl 
iodide also gave a reasonably efficient reaction thanks to 
the use of Pd(OAc)2 (Table 4, entries 15 and 16).
Conclusions
Eight new chiral RTILs were prepared using novel 
and/or carefully optimized synthetic routes. This series 
of imidazolinium, imidazolium and pyridinium ionic 
liquids were fully characterized, including differential 
scanning calorimetry (DSC) analysis. The Heck reaction of 
substituted aza-endocyclic acrylates using arenediazonium 
tetrafluoroborates and aryl iodides as electrophiles were 
investigated in these new RTILs. A strong influence of 
the counter-ion was observed, with the lipophilic RTILs 
providing the best results. The Heck arylations performed 
in these chiral ionic entities, either as a solvent or an 
additive, were effective leading to complete conversion of 
the substrate and good to excellent yield of the Heck adduct. 
In spite of the overall performance of the Heck arylations in 
all the cases studied no asymmetric induction was detected. 
Two new diastereoisomeric NHC-palladium complexes 
were prepared in moderate yields and their structure 
characterized by X-ray diffraction analysis thus allowing 
the identification of the unusual cis-syn stereoisomer 23b. 
Overall, the Heck arylations employing arenediazonium 
tetrafluoroborates in RTILs were more effective than the 
traditional protocols employing aryl iodides in terms of 
reactivity and yields. Applications of the new chiral RTILs 
described herein to other synthetic transformations are in 
progress and the results concerning these studies will be 
reported in due course.
Experimental
General
Reagents and solvents are commercial grade and were 
used as supplied, except when specified in the experimental 
procedure. CH2Cl2 was distilled from calcium hydride and 
THF was distilled from Na. Reactions were monitored by 
TLC analysis using Merck Silica Gel 60 F-254 thin layer 
plates. Flash column chromatography was performed on Acros 
silica gel 60, 0.040-0.063 mm. 1H NMR and 13C NMR data 
were recorded on a Varian Gemini 2000 (300 MHz for 1H and 
75 MHz for 13C NMR), Varian Inova (500 MHz for 1H and 
125 MHz for 13C NMR) or Bruker Avance (250 MHz for 1H 
and 63 MHz for 13C NMR or 300 MHz for 1H and 75 MHz for 
13C NMR) spectrometer using as internal standard the residual 
nondeuterated solvent (CHCl3, CH3OH, acetone or DMSO) or 
TMS (1H NMR). Data are reported as follows: chemical shift 
N N
n-BuI, CH3CN,
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H
O O
H
NH4OH+Ph
Me
NH2 Me
Ph
N
N
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Scheme 8. Preparation of the chiral imidazolium ionic liquid 35.
in ppm (d), multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet, br = broad signal), coupling constant 
(Hz), integration. High-resolution mass spectra (HRMS) were 
measured on a VG Auto-spec-Micromass spectrometer (EI) 
or in a Waters Q-Tof Ultima API (ESI). Infrared spectra (IR) 
were obtained on a Thermo-Nicolet IR-200 spectrometer and 
absorptions are reported in reciprocal centimeters. Melting 
points were recorded on an Electrothermal 9100 melting 
point apparatus and are uncorrected. Differential scanning 
calorimetry (DSC) analyses were recorded on a DSC Diamond 
Perkin Elmer.
General procedures for the quaternarization
A solution of imidazoline 10 or imidazole 14 (1 equiv.) 
and alkyl halide (3.0-5.0 equiv.) in 1,1,1-trichloroethane 
or acetonitrile (0.6 mL mmol-1) was refluxed until TLC 
monitoring showed complete consumption of the starting 
material (2-3 days). For the reaction in 1,1,1-trichloroethane, 
the insoluble oily material was separated by decantation 
and washed several times with 1,1,1-trichloroethane to give 
the expected halide salt. For the reaction in acetonitrile, the 
mixture was concentrated to dryness and partitioned between 
Et2O and water. After two additional extractions with Et2O, 
the aqueous phase was concentrated to dryness to give the 
expected halide salt.
General procedure for the anion metathesis with lithium 
bis(trifluoromethanesulfonyl)imide
A solution of halide salt (1.0 equiv.) in water (6.5 mL mmol-1) 
containing lithium bis(trifluoromethanesulfonyl)imide 
(1.1 equiv.) was heated with stirring at 70 °C for 2 h and 
allowed to stand at room temperature overnight. The insoluble 
oily material was extracted with dichloromethane and the 
organic layer was separated and washed with water and brine, 
dried over Na2SO4, filtered and concentrated to dryness to give 
the expected bis(trifluoromethanesulfonyl)imide salt.
General procedure for the Heck coupling with arenediazonium 
salts in ionic liquids
To a solution of olefin 6 (1 equiv., typically 0.25 mmol) in 
ionic liquid (4.0 mL mmol-1) was added, at once, a mixture of 
the 4-fluorobenzenediazonium tetrafluoroborate (1.5 equiv.) 
and Pd pre-catalyst (5-10 mol%). The reaction mixture was 
immersed in an oil bath and heated under stirring (see tables 
for the temperature and reaction time). After cooling, the 
mixture was extracted (6 × 40 mL mmol-1) with Et2O and 
with 1,1,1-trichloroethane (3 × 40 mL mmol-1). The combined 
organic layers were then concentrated to dryness and purified 
by flash column chromatography over silica gel (petroleum 
ether/ethyl acetate, 4:1) to furnish the desired Heck adduct 7a 
and, in some cases, the corresponding acid 8a.
General procedure for the Heck coupling with aryl iodides 
in ionic liquids
To a solution of olefin 6 (1 equiv., 0.25 mmol) in ionic 
liquid (4.0 mL mmol-1) was added the aryl iodide (3 equiv.), 
Ag2CO3 (1.1 equiv.) and Pd pre-catalyst (5-10 mol%). The 
reaction mixture was immersed in an oil bath and heated under 
stirring (see tables for the temperature and reaction time). After 
cooling, the mixture was extracted with Et2O (6 × 10 mL) and 
with 1,1,1-trichloroethane (3 × 10 mL). The combined organic 
layers were then concentrated to dryness and purified by flash 
column chromatography over silica gel (petroleum ether/ethyl 
acetate, 4:1) to furnish the arylated product 7a,b.
Specific procedures and compounds data
3-Pentyl-1-((1S)-1-phenylethyl)-4,5-dihydro-1H-imidazolium 
bromide (11)
Prepared from imidazoline 10 (1.0 g, 5.75 mmol) 
according to the general procedure for quaternarization 
in 1,1,1-trichloroethane. Bromide 11 (1.80 g, 96%) was 
obtained as light brown liquid. [a]25D –6.8 (c 1.20, CHCl3); 
IR n
max
/cm-1: 2933, 2872, 1646, 1495, 1455, 1382, 1255, 1201, 
1142, 703 (thin film); 1H NMR (300 MHz, CDCl3) d 9.76 (s, 
1H), 7.28-7.42 (m, 5H), 5.06 (q, J  7.0 Hz, 1H), 3.95-3.84 (m, 
2H), 3.79-3.64 (m, 4H), 1.79 (d, J  7.0 Hz, 3H), 1.71-1.60 (m, 
2H), 1.35-1.23 (m, 4H), 0.87 (t, J  7.0 Hz, 3H); 13C NMR (75 
MHz, CDCl3) d 156.6 (CH), 137.3 (C0), 129.0 (CH), 128.6 
(CH), 126.7 (CH), 57.6 (CH), 48.2 (CH2), 48.0 (CH2), 46.3 
(CH2), 28.1 (CH2), 26.8 (CH2), 21.9 (CH2), 19.5 (CH3), 13.6 
(CH3); MS (ESI +) m/z: 245 [M+]; MS (ESI–) m/z: 79, 81 
[Br–]; HRMS (ESI +) m/z: Calcd for C16H25N2 [M+] 245.2018, 
Found 245.2021.
3-Pentyl-1-((1S)-1-phenylethyl)-4,5-dihydro-1H-imidazolium 
hexafluorophosphate (12)
To a stirred solution of imidazolinium bromide 11 
(1.97 g, 6.04 mmol) in water (12 mL) at 0 °C was added 
hexafluorophosphoric acid (1.16 mL of a 60% solution in H2O, 
7.85 mmol, 1.3 equiv.). The stirring was continued at 0 °C for 
2 h and the solution was allowed to stand at room temperature 
overnight. The reaction mixture was then extracted with 
CH2Cl2 and the combined organic layers were washed with 
water, dried over Na2SO4, filtered and concentrated to dryness 
to give 12 (1.52 g, 64%), obtained as a light yellow solid. 
[a]25D –4.0 (c 1.50, CHCl3); mp 86-87 °C; IR nmax/cm-1: 2935, 
1659, 1451, 1383, 1344, 1297, 1258, 1200, 1144, 827, 764, 
705 (thin film); 1H NMR (300 MHz, CDCl3) d 7.98 (s, 1H), 
7.46-7.26 (m, 5H), 4.76 (q, J  6.8 Hz, 1H), 3.96-3.81 (m, 2H), 
3.80-3.68 (m, 2H), 3.50 (t, J  7.6 Hz, 2H), 1.72 (d, J  6.9 Hz, 
3H), 1.69-1.59 (m, 2H), 1.40-1.21 (m, 4H), 0.89 (t, J  6.9 Hz, 
3H); 13C NMR (75 MHz, CDCl3) d 155.2 (CH), 137.4 (C0), 
129.3 (CH), 128.9 (CH), 126.7 (CH), 58.2 (CH), 48.5 (CH2), 
47.9 (CH2), 46.8 (CH2), 28.3 (CH2), 26.7 (CH2), 22.0 (CH2), 
19.1 (CH3), 13.7 (CH3); MS (ESI +) m/z: 245 [M+]; MS 
(ESI –) m/z: 145 [PF6–]; HRMS (ESI +) m/z: Calcd for C16H25N2 
[M+] 245.2018, found 245.2028; HRMS (ESI +) m/z: Calcd 
for PF6 [PF6–] 144.9642, found 144.9635.
 3-Pentyl-1-((1S)-1-phenylethyl)-4,5-dihydro-1H-imidazolium 
bis(trifluoromethanesulfonyl)imide (13)
Prepared from imidazolinium bromide 11 (1.80 g, 
5.54 mmol) according to the general procedure for the anion 
metathesis with lithium bis(trifluoromethanesulfonyl)imide. 
Salt 13 (2.32 g, 80%) was obtained as a light yellow liquid. 
[a]25D –2.7 (c 1.49, CHCl3); Tg –59 °C; IR nmax/cm-1: 2961, 
1649, 1456, 1350, 1186, 1136, 1056, 788, 739, 703 (thin film); 
1H NMR (300 MHz, CDCl3) d 8.05 (s, 1H), 7.46-7.34 (m, 3H), 
7.32-7.27 (m, 2H), 4.80 (q, J 7.0 Hz, 1H), 3.96-3.84 (m, 2H), 
3.82-3.70 (m, 2H), 3.48 (t, J 7.6 Hz, 2H), 1.71 (d, J 6.9 Hz, 3H), 
1.68-1.58 (m, 2H), 1.39-1.20 (m, 4H), 0.89 (t, J 7.0 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) d 155.3 (CH), 137.1 (C0), 129.4 (CH), 
129.1 (CH), 126.7 (CH), 119.8 (q, JC-F  321.3 Hz, SO2CF3), 58.2 
(CH3), 48.6 (CH2), 48.0 (CH2), 46.7 (CH2), 28.3 (CH2), 26.8 
(CH2), 22.0 (CH2), 19.1 (CH3), 13.7 (CH3); MS ESI +) m/z: 245 
[M+]; MS (ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) m/z: Calcd 
for C16H25N2 245.2018 [M+], found 245.2029; HRMS (ESI –) 
m/z: Calcd for C2NO4F6S2 279.9173 [NTf2–], found 279.9190.
3-Pentyl-1-((1S)-1-phenylethyl)-1H-imidazolium bromide (15)
Prepared from imidazole 14 (284 mg, 1.65 mmol) 
according to the general procedure for quaternarization in 
1,1,1-trichloroethane. Imidazolium 15 (530 mg, quant.) was 
obtained as light brown liquid. [a]25D –13.2 (c 1.80, CHCl3); 
IR n
max
/cm-1: 3056, 2957, 2871, 1672, 1561, 1456, 1382, 
1162, 732(thin film); 1H NMR (300 MHz, CDCl3) d 10.77 
(s, 1H), 7.47-7.41 (m, 2H), 7.40-7.32 (m, 4H), 7.28-7.25 (m, 
1H), 5.99 (q, J 7.0 Hz, 1H), 4.35 (t, J 7.4 Hz, 2H), 2.00 (d, J 
7.4 Hz, 3H), 1.92 (quintet, J 7.4 Hz, 2H), 1.37-1.24 (m, 4H), 
0.85 (t, J 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 137.5 
(CH), 135.1 (C0), 128.5 (CH), 128.4 (CH), 126.2 (CH), 121.9 
(CH), 120.4 (CH), 58.9 (CH), 49.2 (CH2), 29.2 (CH2), 27.5 
(CH2), 21.3 (CH2), 20.5 (CH3), 13.1 (CH3); MS (ESI +) m/z: 
243 [M+]; MS (ESI –) m/z: 79, 81 [Br–]; HRMS (ESI +)
 
m/z: 
Calcd for C16H23N2 [M+] 243.1861, found 243.1865.
3-Methyl-1-((1S)-1-phenylethyl)-1H-imidazolium iodide (16)
A solution of imidazole 14 (166 mg, 0.96 mmol) and 
iodomethane (120 μL, 1.30 mmol, 1.35 equiv.) in acetonitrile 
(2.0 mL) was stirred at room temperature for 20 h. The solution 
was concentrated to dryness to give 16 (300 mg, quant.) as 
a light yellow oil. [a]25D +4.3 (c 5.3, CHCl3); IR nmax/cm-1: 
3120, 2934, 1604, 1572, 1496, 1330, 1156, 721 (thin film); 
1H NMR (300 MHz, CDCl3) d 10.19 (s, 1H), 7.57 (t, J 1.7 
Hz, 1H), 7.51-7.37 (m, 5H), 7.34 (t, J 1.8 Hz, 1H), 5.89 (q, 
J 7.0 Hz, 1H), 4.14 (s, 3H), 2.06 (d, J 7.0 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) d 137.5 (CH), 135.9 (C0), 129.3 (CH), 
126.9 (CH), 123.8 (CH), 120.8 (CH), 59.9 (CH), 37.1 (CH3), 
21.4 (CH3); MS (ESI +) m/z: 187 [M+]; MS (ESI –) m/z: 127 
[I–]; HRMS (ESI +) m/z: Calcd for C12H15N2 [M+] 187.1235, 
found 187.1237.
3-(3-cyanopropyl)-1-((1S)-1-phenylethyl)-1H-imidazolium 
chloride (17)
Prepared from imidazole 14 (1.04 g, 6.03 mmol) according 
to the general procedure for quaternarization in acetonitrile. 
Chloride 17 (1.66 g, quant.) was obtained as light yellow oil. 
[a]25D –1.2 (c 1.07, CHCl3); IR nmax/cm-1: 3057, 2938, 2467, 
2247, 1558, 1496, 1456, 1258, 1158, 1014, 878, 853, 753, 
706, 660 (thin film); 1H NMR (300 MHz, CDCl3) d 10.68 (s, 
1H), 7.82 (s, 1H), 7.27-7.21 (m, 5H), 7.15 (s, 1H), 5.68 (q, 
J 6.9 Hz, 1H), 4.57 (t, J 6.7 Hz, 2H), 2.58 (t, J 6.9 Hz, 2H), 
2.28 (quintet, J 6.7 Hz, 2H), 1.89 (d, J 6.9 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) d 137.7 (CH), 129.3 (CH), 126.7 (CH), 
123.0 (CH), 120.7 (CH), 118.6 (C0), 60.0 (CH), 48.3 (CH2), 
26.1 (CH2), 21.1 (CH3), 14.4 (CH2); MS (ESI +) m/z: 240 
[M+]; HRMS (ESI +)
 
m/z: Calcd for C15H18N3 [M+] 240.1501, 
found 240.1481.
3-Pentyl-1-((1S)-1-phenylethyl)-1H-imidazolium 
bis(trifluoromethanesulfonyl)imide (18)
Prepared from imidazolium bromide 15 (909 mg, 
2.81 mmol) according to the general procedure for the anion 
metathesis with lithium bis(trifluoromethanesulfonyl)imide. 
Salt 18 (1.30 g, 88%) was obtained as a light yellow liquid. 
[a]25D –8.1 (c 1.73, CHCl3); Tg –57 °C; IR nmax/cm-1: 3146, 
2962, 1557, 1557, 1457, 1349, 1186, 1136, 1055, 789, 704 
(thin film); 1H NMR (300 MHz, CDCl3) d 8.87 (s, 1H), 
7.46-7.37 (m, 3H), 7.36-7.32 (m, 2H), 7.31-7.28 (m, 1H), 
7.25-7.22 (m, 1H), 5.67 (q, J 7.0 Hz, 1H), 4.18 (t, J 7.5 Hz, 
2H), 1.95 (d, J 7.0 Hz, 3H), 1.86 (quintet, J 7.5 Hz, 2H), 
1.42-1.22 (m, 4H), 0.88 (t, J 7.0 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) d 137.5 (CH), 134.3 (C0), 129.5 (CH), 126.7 (CH), 
122.5 (CH), 121.0 (CH), 119.8 (q, JC-F  321.4 Hz, SO2CF3), 
60.1 (CH), 50.2 (CH2), 29.7 (CH2), 28.0 (CH2), 21.8 (CH2), 
20.6 (CH3), 13.6 (CH3); MS (ESI +) m/z: 243 [M+]; MS 
(ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) m/z: Calcd for 
C16H23N2 [M+] 243.1861, found 243.1865; HRMS (ESI –) 
m/z: Calcd for C2NO4F6S2 [NTf2–] 279.9173, found 279.9170.
3-Methyl-1-((1S)-1-phenylethyl)-1H-imidazolium 
bis(trifluoromethanesulfonyl)imide (19)
Prepared from imidazolium iodide 16 (300 mg, 0.95 mmol) 
according to the general procedure for the anion metathesis 
with lithium bis(trifluoromethanesulfonyl)imide. Salt 19 
(350 mg, 79%) was obtained as a light yellow liquid. [a]25D 
–4.3 (c 2.8, CHCl3); Tg –50 °C; IR nmax/cm-1: 3154, 2989, 
1621, 1572, 1457, 1345, 1194, 1137, 1055, 707 (thin film); 
1H NMR (300 MHz, CDCl3) d 8.73 (s, 1H), 7.45-7.36 (m, 
3H), 7.35-7.30 (m, 2H), 7.28 (t, J 1.8 Hz, 1H), 7.21 (t, J 1.8 
Hz, 1H), 5.60 (q, J 7.0 Hz, 1H), 3.91 (s, 3H), 1.93 (d, J 7.0 
Hz, 3H); 13C NMR (75 MHz, CDCl3) d 137.3 (CH), 135.0 
(C0), 129.6 (CH), 129.5 (CH), 126.7 (CH), 123.8 (CH), 
121.0 (CH), 119.8 (q, JC-F 318.7 Hz, SO2CF3), 60.2 (CH), 
36.4 (CH3), 20.6 (CH3); MS (ESI +) m/z: 187 [M+]; MS 
(ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) m/z: Calcd for 
C12H15N2 [M+] 187.1235, found 187.1235; HRMS (ESI –) 
m/z: Calcd for C2NO4F6S2 [NTf2–] 279.9173, found 279.9164.
3-(3-cyanopropyl)-1-((1S)-1-phenylethyl)-1H-imidazolium 
bis(trifluoromethanesulfonyl)imide (20)
Prepared from imidazolium chloride 17 (1.66 g, 
6.03 mmol) according to the general procedure for the anion 
metathesis with lithium bis(trifluoromethanesulfonyl)imide. 
Salt 20 (2.54 g, 81%) was obtained as a light yellow liquid. 
[a]25D –4.5 (c 1.78, CH3OH); Tg –46 °C; IR nmax/cm-1: 3153, 
2251, 1561, 1457, 1351, 1180, 1141, 1054, 740, 704, 614, 
570 (thin film); 1H NMR (300 MHz, acetone-d6) d 9.23 (t, 
J 1.6 Hz, 1H), 7.82 (t, J 1.9 Hz, 1H), 7.76 (t, J 1.9 Hz, 1H), 
7.44-7.34 (m, 5H), 5.84 (q, J 7.0 Hz, 1H), 4.48 (t, J 7.1 Hz, 
2H), 2.59 (t, J 7.4 Hz, 2H), 2.32 (quintet, J 7.2 Hz, 2H), 1.96 
(d, J 7.0 Hz, 3H); 13C NMR (75 MHz, CD3OD) d 140.0 (CH), 
130.5 (CH), 130.3 (CH), 127.9 (CH), 124.1 (CH), 123.1 (CH), 
121.2 (q, JCF 320.5 Hz, SO2CF3), 119.8 (C0), 61.4 (CH), 49.7 
(CH2), 26.8 (CH2), 21.2 (CH3), 14.7 (CH2); MS (ESI +) m/z: 
240 [M+]; MS (ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) m/z: 
Calcd for C15H18N3 [M+] 240.1501, found 240.1481.
Diaminocarbene palladium complexes 23a,b
Pd(OAc)2 (47 mg, 0.21 mmol) and 3-pentyl-1-[(1S)-1-
phenylethyl]-1H-imidazolium bromide 15 (135 mg, 0.42 
mmol) were dissolved in 7.0 mL of dry THF. After refluxing 
for 6 h under argon and cooling to room temperature, the 
mixture was filtered through a pad of silica gel. The solvent 
was removed under vacuum and the crude product was purified 
by flash column chromatography (petroleum ether/ethyl 
acetate, 4:1) to furnish a 1:1 mixture of compound 23a,b (85 
mg, 54%), obtained as a pale yellow amorphous solid. [a]25D 
–190.0 (c 1.17, CHCl3); mp: 114-116 °C; IR nmax/cm-1: 3156, 
3124, 3094, 3060, 2957, 2929, 2867, 1602, 1560, 1497, 1453, 
1425, 1378, 1216, 1184, 770, 734, 703 (thin film); 1H NMR 
(300 MHz, CDCl3) d 7.67 (d, J 7.1 Hz, 2H), 7.57 (d, J 6.8 Hz, 
2H), 7.43-7.28 (m, 6H), 6.86 (q, J 7.2 Hz, 1H), 6.80 (d, J 1.8 
Hz, 1H), 6.78 (d, J 1.8 Hz, 1H), 6.76 (q, J 7.2 Hz, 1H), 6.57 
(apparent d, J 7.1 Hz, 1H), 6.55 (apparent d, J 1.9 Hz, 1H), 
4.61-4.35 (m, 4H), 2.19-2.04 (m, 4H), 2.01 (d, J 7.1 Hz, 3H), 
1.89 (d, J 7.1 Hz, 3H), 1.50-1.40 (m, 4H), 1.37-1.27 (m, 4H), 
0.96 (apparent t, J 6.9 Hz, 3H), 0.80 (apparent t, J 6.8 Hz, 3H); 
13C NMR (75 MHz, CDCl3) d 168.9 (C0), 168.8 (C0), 140.2 
(C0), 139.9 (C0), 128.6 (CH), 128.6 (CH), 128.0 (CH), 127.9 
(CH), 127.8 (CH), 127.7 (CH), 58.3 (2 CH), 51.2 (CH2), 51.1 
(CH2), 30.6 (CH2), 30.5 (CH2), 29.2 (CH2), 29.0 (CH2), 22.4 
(CH2), 22.3 (CH2), 20.3 (CH3), 20.2 (CH3), 14.0 (CH3), 13.9 
(CH3); MS (ESI +) m/z: 671 [M-Br] (most abundant isotopic 
distribution); HRMS (ESI +)
 
m/z: Calc. for C32H44N4BrPd 
[M-Br] 671.1783, found 671.1818 (most abundant isotopic 
distribution).
1-isopropyl-3-((S)-1-methylpyrrolidin-2-yl)pyridinium iodide 
(28)
A solution of (–)-nicotine (27) (406 mg, 2.50 mmol) and 
2-iodopropane (250 μL, 2.55 mmol) in acetonitrile (2.5 mL) 
was heated at 100 °C in a sealed tube under microwave 
irradiation (150 W) for 2 h. Next, the volatiles were removed 
under reduced pressure and the residue obtained was dissolved 
in water (50 mL). The resulting solution was extracted 
with diethyl ether (2 × 60 mL) and the aqueous layer was 
concentrated to dryness under reduced pressure to give the 
desired pyridinium iodide 28 (1.49 g, 92%), obtained as a dark 
red viscous oil. [a]25D –65.3 (c 1.68, CH3OH); IR nmax/cm-1: 
3023, 2971, 2789, 1497, 1462, 1269, 1149, 731, 691 (thin 
film); 1H NMR (300 MHz, CD3OD) d 9.18 (s, 1H), 9.07 (d, 
J 6.1 Hz, 1H), 8.67 (d, J 8.0 Hz, 1H), 8.14 (apparent t, 
J 7.4 Hz, 1H), 5.12 (septet, J 6.7 Hz, 1H), 4.00-3.75 (m, 
1H), 3.42 (apparent t, J 9.6 Hz, 1H), 2.67 (apparent q, 
J 8.6 Hz, 1H), 2.58-2.30 (superposed multiplet, 1H and a singlet 
centered at 2.40, 3H), 2.19-1.85 (m, 3H), 1.75 (d, J 6.7 Hz, 
6H); 13C NMR (75 MHz, CD3OD) d 146.2 (CH), 145.2 (C0), 
143.5 (CH), 143.1 (CH), 129.7 (CH), 68.8 (CH), 66.7 (CH), 
57.8 (CH2), 40.6 (CH), 35.5 (CH2), 23.8 (CH2), 23.3 (CH3), 
23.2 (CH3); MS (ESI +) m/z: 205 [M+]; HRMS (ESI +) m/z: 
Calcd for C13H21N2 [M+] 205.1705, found 205.1713.
1-isopropyl-3-((S)-1-methylpyrrolidin-2-yl)pyridinium 
bis(trifluoromethanesulfonyl)imide (29)
Prepared from pyridinium iodide 28 (1.07 g, 3.23 mmol) 
according to the general procedure for the anion metathesis 
with lithium bis(trifluoromethanesulfonyl)imide. Pyridinium 
29 (1.04 g, 66%) was obtained as a light brown oil. [a]25D 
–69.2 (c 1.59, CHCl3); Tg –56 °C; IR nmax/cm-1: 3073, 2977, 
2948, 2791, 1499, 1465, 1352, 1268, 1196, 1138, 1059, 739 
(thin film); 1H NMR (300 MHz, CDCl3) d 8.79-8.76 (m, 2H), 
8.46 (apparent d, J 8.0 Hz, 1H), 8.02 (dd, J 6.2 and 7.9 Hz, 
2H), 5.02 (septet, J 6.7 Hz, 1H), 3.55 (t, J 8.1 Hz, 1H), 3.27 
(ddd, J 2.8, 7.2 and 9.6 Hz, 3H), 2.48 (q, J 8.3 Hz, 1H), 2.41 
(tdd, J 6.5, 8.8 and 12.9 Hz, 1H), 2.24 (s, 3H), 2.03-1.82 (m, 
2H), 1.80-1.59 (doublet centered at 1.71, J 6.7 Hz, 6H, and 
a superposed multiplet, 1H); 13C NMR (75 MHz, CDCl3) d 
147.2 (C0), 144.6 (CH), 141.1 (CH), 140.7 (CH), 128.7 (CH), 
119.8 (q, JC-F 319.5 Hz, SO2CF3), 67.0 (CH), 65.5 (CH), 56.6 
(CH2), 40.2 (CH), 35.7 (CH2), 23.1 (CH2), 23.1 (CH3), 23.0 
(CH3); MS (ESI +) m/z: 205 [M+]; MS (ESI –) m/z: 280 [NTf2–]; 
HRMS (ESI +) m/z: calcd for C13H21N2 [M+] 205.1705, found 
205.1710.
(S)-1-((1-ethylpyrrolidin-2-yl)methyl)pyridinium chloride (31)
To a suspension of 1-(2,4-dinitrophenyl)pyridinium 
chloride (25) (2.30 g, 8.17 mmol) in n-butanol (80.0 mL) 
was added (S)-2-(aminomethyl)-1-ethylpyrrolidine (1.01 g, 
7.96 mmol) and the resulting mixture was refluxed for 20 h. 
After cooling to room temperature, the solvent was removed 
under reduced pressure and water (60.0 mL) was added to 
the residue obtained. The aqueous solution was washed with 
dichloromethane (3 × 80 mL) and concentrated to dryness 
under reduced pressure. The brown oil obtained was purified 
by flash column chromatography (dichloromethane/methanol, 
9:1 to 1:1 + 3 drops of NH4OH/10 mL of eluent) to furnish 
the pyridinium chloride 31 (1.88 g, 51%), obtained as a light 
yellow viscous oil. [a]25D +1.3 (c 1.17, CH3OH); IR nmax/cm-1: 
3044, 2974, 2612, 2505, 1581, 1490, 1455, 1187, 1055, 777, 
729 (thin film); 1H NMR (300 MHz, CD3OD) d 9.30 (d, J 
5.8 Hz, 2H), 8.74 (apparent t, J 7.9 Hz, 1H), 8.24 (dd, J 6.8 
and 7.4 Hz, 2H), 5.27 (AB of an ABX, Δδ = 0.36, J 5.6, 8.7 
and 13.7 Hz, 2H), 4.26 (quintet, J 7.3 Hz, 1H), 3.90-3.82 (m, 
1H), 3.53-3.19 (m, 3H), 2.31-1.99 (m, 4H), 1.40 (t, J 7.2 Hz, 
3H); 13C NMR (75 MHz, CD3OD) d 148.5 (CH), 146.9 (CH), 
130.1 (CH), 67.6 (CH), 61.0 (CH2), 55.2 (CH2), 51.5 (CH2), 
29.3 (CH2), 22.8 (CH2), 11.1 (CH3); MS (ESI +) m/z: 191 
[M+]; HRMS (ESI +) m/z: Calcd for C12H19N2 [M+] 191.1548, 
found 191.1562.
(S)-1-((1-ethylpyrrolidin-2-yl)methyl)pyridinium 
bis(trifluoromethanesulfonyl)imide (32)
Prepared from pyridinium chloride 31 (1.66 g, 5.90 mmol) 
according to the general procedure for the anion metathesis 
with lithium bis(trifluoromethanesulfonyl)imide. Pyridinium 
32 (1.85 g, 67%) was obtained as a light brown viscous oil. 
[a]25D +5.6 (c 1.05, CH3OH); Tg –52 °C; IR nmax/cm-1: 3138, 
3095, 3072, 2976, 2872, 2812, 1490, 1456, 1353, 1196, 1137, 
1059, 790, 740 (thin film); 1H NMR (300 MHz, CD3OD) 
d 8.98 (apparent d, J 5.6 Hz, 2H), 8.65 (apparent t, J 7.9 Hz, 
1H), 8.14 (apparent t , J 7.4 Hz, 2H), 4.79-4.66 (m, 2H), 3.58-
3.44 (m, 1H), 3.42-3.29 (m superposed with the solvent peak, 
1H), 3.00-2.58 (m, 3H), 2.18-2.01 (m, 1H), 2.00-1.82 (m, 1H), 
1.81-1.56 (m, 2H), 1.14 (t, J 7.2 Hz, 3H); 13C NMR (75 MHz, 
CD3OD) d 147.6 (CH), 146.8 (CH), 129.2 (CH), 121.2 (q, 
JC-F 320.3 Hz, SO2CF3), 65.6 (CH), 63.7 (CH2), 54.6 (CH2), 
50.7 (CH2), 28.9 (CH2), 23.9 (CH2), 13.0 (CH3); MS (ESI +) 
m/z: 191 [M+]; MS (ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) 
m/z: Calcd for C12H19N2 [M+] 191.1548, found 191.1582.
(S)-2-(1-(1-phenylethyl)-1H-imidazol-2-yl)pyridine (33)
To a solution of (S)-a-methylbenzylamine (2.25 g, 
18.6 mmol) and aqueous ammonia (2.0 mL, 37.2 mmol) in 
propan-1-ol (10.0 mL) at 0 °C was added dropwise a solution 
of glyoxal (2.34 mL, 20 mmol) and 2-pyridinecarboxaldehyde 
(1.9 mL, 20 mmol) in propan-1-ol (20 mL). After 1 h at 0 °C, 
the solution was heated to 80 °C and left stirring for 4 h. It 
was then cooled to room temperature and water was added. 
Subsequently, the mixture was extracted with dichloromethane 
(3 × 100 mL) and the combined extracts were washed with 
water (2 × 100 mL), dried over anhydrous Na2SO4, filtered 
and the dichloromethane removed under reduced pressure. 
The brown oil obtained was purified by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1) to furnish 
imidazole 33 (0.84 g, 18%), obtained as a light brown oil. 
[a]25D –244.4 (c 1.00, CHCl3); IR nmax/cm-1: 3108, 3046, 2981, 
2936, 1589, 1566, 1484, 1451, 1404, 1265, 1149, 1093, 1023, 
792, 738, 700 (thin film); 1H NMR (300 MHz, CDCl3) d 8.59 
(dt, J 0.8 and 4.8 Hz, 1H), 8.19 (dd, J 0.5 and 8.0 Hz, 2H), 
7.75 (tdd, J 0.5, 1.8 and 8.0 Hz, 1H), 7.36-7.16 (m, 7H and a 
superposed bs centered at 7.18, 1H), 7.10 (bs, 1H), 1.88 (d, J 
7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 151.0 (C0), 148.1 
(CH), 144.6 (C0), 142.2 (C0), 136.5 (CH), 128.6 (CH), 128.4 
(CH), 127.3 (CH), 126.4 (CH), 123.2 (CH), 122.4 (CH), 119.7 
(CH), 54.8 (CH), 21.6 (CH3); MS (ESI +) m/z: 250 [M+H+]; 
HRMS (ESI +) m/z: Calcd for C16H16N3 [M+H+] 250.1344, 
found 250.1346.
(S)-3-butyl-1-(1-phenylethyl)-2-(pyridin-2-yl)-1H-imidazol-
3-ium iodide (34)
A solution of imidazole 33 (500 mg, 2.00 mmol) and 
1-iodobutane (1.14 mL, 10.0 mmol) in acetonitrile (4.0 mL) 
was heated at 100 °C in a sealed tube under microwave 
irradiation (150 W) for 2 h. Next, the volatiles were removed 
under reduced pressure, and the residue obtained was dissolved 
in water (70.0 mL). A saturated NaCl solution (30.0 mL) was 
added and the resulting solution was extracted with diethyl 
ether (2 × 80 mL) and dichloromethane (3 × 90 mL). The 
combined dichloromethane extracts were dried over anhydrous 
Na2SO4, filtered and concentrated under reduced pressure 
to give the desired imidazolium iodide 34 (0.72 g, 83%), 
obtained as a light yellow oil. [a]25D –109.4 (c 1.56, CHCl3); 
IR n
max
/cm-1: 3089, 3054, 2960, 2934, 2873, 2190, 1594, 1571, 
1499, 1455, 1427, 1221, 1190, 920, 800, 727, 702 (thin film); 
1H NMR (300 MHz, CDCl3) d 8.82 (ddd, J 1.0 , 1.7 and 4.8 Hz, 
1H), 8.32-8.19 (m, 1H), 8.07 (apparent td, J 1.7 and 7.8 Hz, 1H), 
7.95 (s, 1H), 7.66-7.60 (m, 2H), 7,33-7,24 (m, 3H), 7.21-7.12 
(m, 2H), 5.70 (q, J 6.9 Hz, 1H), 4.23 (quintet of d, J 2.4 and 
7.4 Hz, 2H), 1.96 (d, J 7.7 Hz, 3H), 1.76 (quintet, J 7.5 Hz, 
2H), 1.24 (quintet, J 7.4 Hz, 2H), 0.80 (t, J 7.3 Hz, 3H); 13C 
NMR (75 MHz, CDCl3) d 150.9 (CH), 142.0 (C0), 141.1 (C0), 
138.3 (CH), 137.5 (C0), 129.1 (CH), 128.9 (CH), 128.3 (CH), 
126.8 (CH), 126.4 (CH), 123.0 (CH), 119.9 (CH), 58.4 (CH), 
49.4 (CH2), 31.6 (CH2), 21.1 (CH3), 19.3 (CH2), 13.2 (CH3); 
MS (ESI +) m/z: 306 [M+]; MS (ESI –) m/z: 127 [I–]; HRMS 
(ESI +) m/z: Calcd for C20H24N3 [M+] 306.1970, found 306.2000.
(S)-3-butyl-1-(1-phenylethyl)-2-(pyridin-2-yl)-1H-imidazol-
3-ium bis(trifluoromethanesulfonyl)imide (35)
Prepared from imidazolium iodide 34 (274 mg, 0.63 
mmol) according to the general procedure for the anion 
metathesis with lithium bis(trifluoromethanesulfonyl)imide. 
Imidazolium 35 (339 mg, 92%) was obtained as a light brown 
oil. [a]25D –97.6 (c 1.36, CHCl3); Tg –40 °C; IR nmax/cm-1: 
3142, 3067, 2966, 2939, 2878, 1595, 1573, 1499, 1455, 
1353, 1332, 1226, 1195, 1138, 1058, 790, 617, 570, 513 
(thin film); 1H NMR (300 MHz, CDCl3) d 8.84 (ddd, J 0.9, 
1.7 and 4.8 Hz, 1H), 8.03 (td, J 1.8 and 7.8 Hz, 1H), 7.83 
(dt, J 1.0 and 7.9 Hz, 1H), 7.62 (ddd, J 1.2, 4.8 and 7.8 Hz, 
1H), 7.54 (d, J 2.1 Hz, 1H), 7.43 (d, J 2.1 Hz, 1H), 7.35-7.29 
(m, 3H), 7.11 (ddd, J 0.5, 2.2 and 5.2 Hz, 1H), 5.63 (q, J 
7.0 Hz, 1H), 4.09 (t, J 7.6 Hz, 2H), 1.89 (d, J 7.0 Hz, 3H), 
1.72 (apparent quintet, J 7.5 Hz, 2H), 1.22 (septet, J 7.5 Hz, 
2H), 0.81 (t, J 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 
151.1 (CH), 142.2 (C0), 141.2 (C0), 138.4 (CH), 137.4 (C0), 
129.3 (CH), 129.2 (CH), 127.5 (CH), 126.9 (CH), 126.4 
(CH), 122.6 (CH), 119.9 (q, JC-F 321.5 Hz, SO2CF3), 119.7 
(CH), 58.6 (CH), 49.2 (CH2), 31.7 (CH2), 20.6 (CH3), 19.3 
(CH2), 13.1 (CH3); MS (ESI +) m/z: 306 [M+]; MS (ESI –) 
m/z: 280 [NTf2–]; HRMS (ESI +) m/z: Calcd for C20H24N3 
[M+] 306.1970, found 306.1982.
Supplementary Information
1H and 13C NMR spectra of compounds 11, 12, 13, 15, 16, 
17, 18, 19, 20, 23, 28, 29, 31, 32, 33, 34 and 35, and selected 
crystallographic data for compounds 23a and 23b are available 
free of charge at http://jbcs.sbq.org.br, as PDF file.
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Crystal Structure Determination
The structures of two compounds were determined. The selected crystals were mounted on a glass fibber using 
perfluoropolyether oil and cooled rapidly in a stream of cold N2. For all the structures data collection were collected at low 
temperature (213 K for compounds 23a and 173 K for compounds 23b) and using a graphite-monochromated MoKa radiation 
(l = 0.71073Å). The structure were solved by direct methods (SHELXS-97, G. M. Sheldrick, Acta Crystallogr. 1990, A46, 
467-473) and all non hydrogen atoms were refined anisotropically using the least-squares method on F2 (SHELXL-97, 
Program for Crystal Structure Refinement, G. M. Sheldrick, University of Göttingen 1997). CCDC 724261 (23a) and CCDC 
724262 (23b) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via 
www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 
336033; e-mail: deposit@ccdc.cam.ac.uk). 
Selected crystallographic data for compound 23a
Selected data for trans-anti Pd complex 23a:  C32 H44 Br2 N4 Pd, M = 750.93, orthorhombic, space group P2(1)2(1)2(1), 
a = 8.7609(2) Å, b = 12.0766(3) Å, c = 31.6211(9) Å, a = b = g = 90°, V =3345.57(15) Å3, Z = 4, crystal size 0.35 x 0.15 x 
0.05 mm3, 32050 reflections collected (6787 independent, Rint = 0.0821), 383 parameters, R1 [I>2s(I)] = 0.0423, wR2 [all 
data] = 0.0804, largest diff. peak and hole: 0.422 and -0.392 eÅ-3.
Selected crystallographic data for compound 23b
Selected data for cis-syn Pd complex 23b:  C33 H46 Br2 Cl2 N4 Pd, M = 835.86, orthorhombic, space group P2(1)2(1)2(1), 
a = 7.7314(8) Å, b = 17.6948(17) Å, c = 27.018(3) Å, a = b = g = 90°, V = 3696.3(6) Å3, Z = 4, crystal size 0.40 x 0.20 x 
0.05 mm3, 33902 reflections collected (9117  independent, Rint = 0.0759),  447 parameters, R1 [I>2s(I)] = 0.0544, wR2 [all 
data] = 0.1145, largest diff. peak and hole: 0.624 and -0.727 eÅ-3.
Figura S1. 1H NMR spectrum (300 MHz, CDCl3) of compound 11.
1H NMR and 13C NMR spectra for compounds 11, 12, 13, 15, 16, 17, 18, 19, 20, 23, 28, 29, 31, 32, 33, 34 and 35
Figura S2. 13C NMR spectrum (75 MHz, CDCl3) of compound 11.
Figura S3. 1H NMR spectrum (300 MHz, CDCl3) of compound 12.
Figura S5. 1H NMR spectrum (300 MHz, CDCl3) of compound 13.
Figura S4. 13C NMR spectrum (75 MHz, CDCl3) of compound 12.
Figura S6. 13C NMR spectrum (75 MHz, CDCl3) of compound 13.
Figura S7. 1H NMR spectrum (300 MHz, CDCl3) of compound 15.
Figura S9. 1H NMR spectrum (300 MHz, CDCl3) of compound 16.
Figura S8. 13C NMR spectrum (75 MHz, CDCl3) of compound 15.
Figura S10. 13C NMR spectrum (75 MHz, CDCl3) of compound 16.
Figura S11. 1H NMR spectrum (300 MHz, CDCl3) of compound 17.
Figura S13. 1H NMR spectrum (300 MHz, CDCl3) of compound 18.
Figura S12. 13C NMR spectrum (75 MHz, CDCl3) of compound 17.
Figura S14. 13C NMR spectrum (75 MHz, CDCl3) of compound 18.
Figura S15. 1H NMR spectrum (300 MHz, CDCl3) of compound 19.
Figura S17. 1H NMR spectrum (300 MHz, acetone-d6) of compound 20.
Figura S16. 13C NMR spectrum (75 MHz, CDCl3) of compound 19.
Figura S18. 13C NMR spectrum (75 MHz, CD3OD) of compound 20.
Figura S19. 1H NMR spectrum (300 MHz, CDCl3) of compound 23a,b.
Figura S21. 1H NMR spectrum (300 MHz, CD3OD) of compound 28.
Figura S20. 13C NMR spectrum (75 MHz, CDCl3) of compound 23a,b.
Figura S22. 13C NMR spectrum (75 MHz, CD3OD) of compound 28.
Figura S23. 1H NMR spectrum (300 MHz, CDCl3) of compound 29.
Figura S25. 1H NMR spectrum (300 MHz, CD3OD) of compound 31.
Figura S24. 13C NMR spectrum (75 MHz, CDCl3) of compound 29.
Figura S26. 13C NMR spectrum (75 MHz, CD3OD) of compound 31.
Figura S27. 1H NMR spectrum (300 MHz, CD3OD) of compound 32.
Figura S29. 1H NMR spectrum (300 MHz, CDCl3) of compound 33.
Figura S28. 13C NMR spectrum (75 MHz, CD3OD) of compound 32.
Figura S30. 13C NMR spectrum (75 MHz, CDCl3) of compound 33.
Figura S31. 1H NMR spectrum (300 MHz, CDCl3) of compound 34.
Figura S33. 1H NMR spectrum (300 MHz, CDCl3) of compound 35.
Figura S32. 13C NMR spectrum (75 MHz, CDCl3) of compound 34.
Figura S34. 13C NMR spectrum (75 MHz, CDCl3) of compound 35.
